Chemoinformaics analysis of Cyanidin-3-O-Glucoside
| Molecular Weight | 484.841 | nRot | 4 |
| Heavy Atom Molecular Weight | 463.673 | nRig | 23 |
| Exact Molecular Weight | 484.077 | nRing | 4 |
| Solubility: LogS | -3.544 | nHRing | 2 |
| Solubility: LogP | 0.007 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 10 | APOL | 60.0747 |
| nHD | 8 | BPOL | 26.2753 |
| QED | 0.203 |
| Synth | 4.25 |
| Natural Product Likeliness | 2.115 |
| NR-PPAR-gamma | 0.898 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.746 |
| HIA | 0.823 |
| CACO-2 | -6.303 |
| MDCK | 0.00000992 |
| BBB | 0.099 |
| PPB | 0.872847 |
| VDSS | 0.883 |
| FU | 0.144906 |
| CYP1A2-inh | 0.104 |
| CYP1A2-sub | 0.041 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.179 |
| CYP2d6-inh | 0.023 |
| CYP2d6-sub | 0.203 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.009 |
| CL | 9 |
| T12 | 0.864 |
| hERG | 0.012 |
| Ames | 0.76 |
| ROA | 0.079 |
| SkinSen | 0.211 |
| Carcinogencity | 0.094 |
| EI | 0.095 |
| Respiratory | 0.035 |
| NR-Aromatase | 0.931 |
| Antiviral | Yes |
| Prediction | 0.842159 |